Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 219.95
-12.48 (-5.37%)
Sep 24, 2026, 11:55 AM IST
Hikal Market Cap
Hikal has a market cap or net worth of 28.7 billion as of September 23, 2026. Its market cap has decreased by -13.46% in one year.
Market Cap
28.70B
Enterprise Value
35.40B
Revenue
17.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
219.95
ChartMarket Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 28.70B, an increase of 2,014.51%. That is a compound annual growth rate of 13.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 28.09B | 0.42% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 63.64B |
| Orchid Pharma | 54.87B |
| RPG Life Sciences | 45.65B |
| Solara Active Pharma Sciences | 36.34B |
| Ind-Swift Laboratories | 32.99B |
| Sakar Healthcare | 25.78B |
| Indoco Remedies | 23.78B |
| Windlas Biotech | 23.31B |